Healthcare JournalSynthetic Biology Market – New Investments Expected to boost the Demand by 2024Healthcare JournalThe global Synthetic Biology Market report includes the definition of the market, applications, uses, classification, product specificati… Continue reading
Endpoints NewsA gene therapy mystery? GenSight blasted as 1st PhIII eye study ends in an intriguing failureEndpoints NewsThe mystery: The other eyes that received a sham therapy did just as well with their eyesight. Exactly as well. That makes the Phas… Continue reading
American Council on Science and Health |
Crispr created foods are different than GMOs, it is wrong for anti-GMO activists to pretend they’re not.
American Council on Science and Health Monsanto, perhaps to rebrand itself, and certainly to remain a leader in agricultural biotech has helped establish and fund Pairwise Plants a start-up using CRISPR-Cas9 technologies to modify seeds. They have given the new company money and their vice … Sweeter Strawberries With A Longer Shelf Life Could Be First Crispr OfferingsPerishableNews (press release) Enough With the Talking AlreadyGenomeWeb |
|
How CRISPR works, explained in two minutes
STAT We’ve traveled through time and space to bring back to life a hallowed surgical theater 3. We’ve followed sound waves 4 through our inner ears into our brains. Of all of these fantastic journeys, one of the hardest subjects to capture, visually, has … |
European Biotechnology |
Cellectis in offering of US$175m ADS following asset swap
European Biotechnology Cellectis’ CAR T platform use engineered T-cells from a healthy donor for use in multiple patients. This is distinct from autologous approaches that use a patient’s own T-cells to target tumor cells. Since manufacturing of autologous CAR T cell … |